Xuemei Hu

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Emergency Department

Binding Protein

Induced Apoptosis

Top Venues

Communications biology

Recent patents on anti-cancer drug discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Wang, Xiaoyue Zhao, Zhidan Li, Wenxiao Wang, Yuzhu Jiang, Haixia Zhang, Xianbing Liu, Yushan Ren, Xiaoyan Xu, Xuemei Hu
Decidual natural killer cells dysfunction is caused by IDO downregulation in dMDSCs with Toxoplasma gondii infection. Communications biology 7 (1) (2024)
Jiaqi Su, Xianbing Liu, Xiaoyue Zhao, Hongjie Ma, Yuzhu Jiang, Xu Wang, Peiyuan Wang, Mingdong Zhao, Xuemei Hu
Curcumin Inhibits the Growth of Hepatocellular Carcinoma via the MARCH1-mediated Modulation of JAK2/STAT3 Signaling. Recent patents on anti-cancer drug discovery (2024)
Yu Wang, Xiaoyue Zhao, Zhidan Li, Wenxiao Wang, Yuzhu Jiang, Haixia Zhang, Xianbing Liu, Yushan Ren, Xiaoyan Xu, Xuemei Hu
Decidual natural killer cells dysfunction is caused by IDO downregulation in dMDSCs with Toxoplasma gondii infection. Communications biology 7 (1) (2024)
Yu Wang, Xiaoyue Zhao, Zhidan Li, Wenxiao Wang, Yuzhu Jiang, Haixia Zhang, Xianbing Liu, Yushan Ren, Xiaoyan Xu, Xuemei Hu
Decidual natural killer cells dysfunction is caused by IDO downregulation in dMDSCs with Toxoplasma gondii infection. Communications biology 7 (1) (2024)
Houbao Qi, Yuantao Li, Xianbing Liu, Yuzhu Jiang, Zhidan Li, Xiaoyan Xu, Haixia Zhang, Xuemei Hu
Tim-3 regulates the immunosuppressive function of decidual MDSCs via the Fyn-STAT3-C/EBPβ pathway during Toxoplasma gondii infection. PLoS pathogens 19 (4) (2023)